Our stories

Kerri and Taylor Rhodes felt helpless as they watched their son struggle with substance use disorder after being prescribed an opioid to help with postoperative pain. When their daughter faced the same procedure years later, the family was determined to find a different way to manage her pain.

APOL1-mediated kidney disease (AMKD) is a serious disease with a high unmet need — exactly the type of problem that fits our research strategy. Hear from experts in our AMKD podcast episode, in partnership with Bloomberg Media Studios.

When reflecting on 2023, it is clear that the Vertex Foundation had another strong year of impact through its nonprofit partnerships in our amazing communities and with the unwavering support of Vertexians.

Listen to Jason McCartney, Senior Director, Medicinal Chemistry, discuss an overview of the drug discovery process at Vertex Pharmaceuticals.

Join us as we celebrate 15 years of giving back at Vertex.

Meet the very first graduating class of Vertex Physicians Investigators. In this Q&A you’ll learn about their biotech journey and what motivates them.

Watch as our Senior Vice President and San Diego Site Head, Sabine Hadida, breaks down our drug discovery process and the importance of grit, teamwork and determination.

We’re investigating type 1 diabetes at the cellular level. Hear from experts in our type 1 diabetes podcast episode, in partnership with Bloomberg Media Studios.

In honor of Pain Awareness Month in the U.S., learn more about Dr. Bertoch’s experience and his hopes for managing pain in the future.

Vertex Pharmaceuticals is a place where you can grow, work and be supported at home. We believe it’s important to not only take care of employees but families as a whole.

The Vertex Foundation aims to help support the entire family — including educational funding for people living with cystic fibrosis, their loved ones and caregivers.

Ex vivo gene-editing therapies are one of the tools we’re investigating to harness cutting-edge science to impact genetic diseases. Learn how this type of therapy is manufactured and prepared.

Our “We” Wins mentality at work. Read about how Vertex employees challenged the status quo and created opportunities to donate retired laptops to students in our communities.

Listen to James Sinclair, ‪Senior Director of Engineering & Applied Physics, talk about how our engineers partner with our scientists to optimize the drug discovery process.

Our high school internship program represents the best of workplace-based learning. Join students in our Learning Lab in San Diego to learn more.

Step inside our Oxford, U.K., Learning Lab and learn about our year 12 summer internship, one of our signature STEAM education programs.

Learn about how mRNA therapy could potentially benefit people living with serious diseases.

Cells are often called the building blocks of life, and cell therapies are one of the ways we’re trying to unlock innovative ways to treat serious diseases.

On World Blood Donor Day, hear from two individuals living with sickle cell disease and transfusion-dependent beta thalassemia as they share their stories, shed light on their struggles, and emphasize the impact blood donation has had on their disease and quality of life.

Paul Negulescu, Senior Vice President, Research, talks about the journey his team has taken over the last 20 years.

Learn about how small molecules can potentially make a big impact on the future of medicine. They are just one of our tools that are being investigated to unlock new ways to impact serious diseases.

Step inside our Boston Learning Lab and learn about our high school summer internship, one of our signature STEAM education programs.

Listen to Fred Van Goor, Vice President of Cystic Fibrosis Research, talk about our commitment to pursuing new therapeutic advances for all people living with cystic fibrosis and how this commitment drives scientific innovation.

Rebecca Hunt, Vice President of Patient and Community Engagement, highlights Vertex’s uncompromising commitment to patients.

Learn about an essential component in stem cell transplants, known as conditioning regimens. This is just one of the tools in our drug discovery toolbox that could support potential treatments.

Learn how Vertex remains committed to increasing representation in science and medicine through our partnership with the Biomedical Science Careers Program.

Learn about one of our innovative approaches, cell encapsulation. This is just one of the tools in our drug discovery toolbox that has the potential to treat serious diseases.

Learn about one of our innovative approaches, CRISPR/Cas9. This is just one of the tools in our drug discovery toolbox that has the potential to unlock new ways to impact genetic diseases.

Mark Higgins, Senior Director of Clinical Development, highlights Vertex’s patient-first approach to clinical trials and discusses his experience discovering potential treatments for people with cystic fibrosis.

Looking back on 2022, the Vertex Foundation remains grateful and excited for the future. From supporting healthy families to social innovation and STEAM education, we’re proud of the impact Foundation partners continue to make in our communities around the world. 

Cystic fibrosis is a rare, genetic, progressive disease, in which symptoms and organ damage can manifest very early in life. These may not, however, be outwardly visible in all children and while some children can appear well on the outside, what is happening inside their bodies can tell a different story. 

We are lucky to have some of our very own ‘Vertexians’ willing to share their stories about living with or caring for someone with T1D. We invite you to learn from them and help raise awareness for T1D this month.

Alonzo Mourning was at the height of his legendary basketball career when he was diagnosed with what is now known as APOL1-mediated kidney disease (AMKD). We’re teaming up to help raise awareness of AMKD and empower others to take a proactive role in their health. (Alonzo Mourning is a paid spokesperson for Vertex Pharmaceuticals.)

Derya Balata and Teame Araya are Vertex’s newest Science Leaders Scholars. Learn more about these two outstanding students who have been selected to receive a four-year, full scholarship to pursue a STEM-related course of study at the University of Massachusetts. 

This September, join us in recognizing Duchenne Action Month by learning from some of our female scientists working on Duchenne muscular dystrophy (DMD). These scientists are passionate about their research and raising awareness for DMD.

Vertex is proud to share that it has been named — once again — to Seramount’s 100 Best Companies list and the Best Companies for Dads list. Learn more about what sets us apart and meet our Working Parents of the Year honorees, Genzy Davis and Ravin Warnakulasuriya. 

Incredible talent and cross-functional collaboration. All that and more with Vertex’s type 1 diabetes team. Meet a few of the team members who are making a difference.